Deepak Nath - Abbott Laboratories Insider

ABT -- USA Stock  

USD 63.06  0.32  0.51%

Senior Vice President - Abbott Vascular
Mr. Deepak S. Nath is Senior Vice President Abbott Vascular of the Company. Currently he is Vice President, Vascular, Commercial. Between 2014 to 2015 he is Vice President, Molecular Diagnostics. Between 2012 to 2014 he is Divisional Vice President and General Manager, Ibis. Between 2011 to 2012 he is Divisional Vice President, CEEMEA, Vascular. Between 2009 to 2011 he is Divisional Vice President and General Manager, Nordics and Eastern European Operations, Vascular.
Age: 43  President Since 2015      

Deepak Nath Latest Insider Activity

Management Efficiency

The company has Return on Asset of 3.05 % which means that on every $100 spent on asset it made $3.05 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 1.19 % implying that it generated $1.19 on every 100 dollars invested.
The company has 22.09 B in debt with debt to equity (D/E) ratio of 69.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Abbott Laboratories has Current Ratio of 1.63 which is typical for the industry and considered as normal.

Similar Executives

Showing few of many executives


Sanat ChattopadhyayMerck Co
Ashley WatsonMerck Co
Shannon HallBio Rad Laboratories
Jeffrey ChodakewitzVertex Pharmaceuticals Incorpor
Jonathon KellermanAllergan plc
Mirian GraddickWeirMerck Co
Blaise ColemanEndo International plc
Hugh ONeillMallinckrodt Public Limited Com
Christi ShawEli Lilly and Company
Steve RomanoMallinckrodt Public Limited Com
Enrique ConternoEli Lilly and Company
Darren CarrollEli Lilly and Company
Karen SantiagoBristol Myers Squibb Company
Wayne SwantonAllergan plc
Thomas GraneyVertex Pharmaceuticals Incorpor
Ian SmithVertex Pharmaceuticals Incorpor
Joshua SmileyEli Lilly and Company
Ann JudgeBristol Myers Squibb Company
Melissa BarnesEli Lilly and Company
Michael PartridgeVertex Pharmaceuticals Incorpor
Johna NortonEli Lilly and Company

Entity Summary

Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide. The company was founded in 1888 and is headquartered in Abbott Park, Illinois. Abbott Laboratories operates under Medical Devices classification in USA and traded on New York Stock Exchange. It employs 99000 people.Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in ILLINOIS, U.S.A and employs 99,000 people. Abbott Laboratories is listed under Pharmaceutical Products category by Fama And French industry classification.

Abbott Laboratories Leadership Team

Scott White, President
Samuel Scott, Director
Deepak Nath, President
Jaime Contreras, President
Roger Bird, President
Nancy McKinstry, Director
Heather Mason, President
James Farrell, Director
Phebe Novakovic, Director
JeanYves Pavee, President
Andrew Lane, President
Roxanne Austin, Director
Georges Vos, President
Stephen Fussell, President
Thomas Freyman, EVP
Sally Blount, Director
Daniel Starks, Director
Michelle Kumbier, Director
Thomas Frinzi, President
Eric Fain, President
John Capek, EVP
Robert Alpern, Director, Ph.D
Murthy Simhambhatla, President
Miles White, Chairman
Robert Ford, President
Glenn Tilton, Director
Richard Ashley, EVP
Michael Rousseau, President
Edward Liddy, Director
Hubert Allen, EVP
Charles Foltz, President
Brian Yoor, CFO
John Stratton, Director
Joseph Manning, President
Jared Watkin, President
William Osborn, Director
Brian Blaser, EVP
Michael Warmuth, President
Robert Funck, President
Daniel Salvadori, President

Stock Performance Indicators

Current Sentiment - ABT

Abbott Laboratories Investor Sentiment
Predominant part of Macroaxis users are presently bullish on Abbott Laboratories. What is your sentiment towards investing in Abbott Laboratories? Are you bullish or bearish?
98% Bullish
2% Bearish

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Abbott Laboratories and IQVIA Holdings. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Insider Screener module to find insiders across different sectors to evaluate their impact on performance.